BOBULSKY SUSAN (SVP, Diagnostics, clonoSEQ) sold 2.6% of their position (11K shares) of ADAPTIVE BIOTECHNOLOGIES CORP on the open market
Open‑market sale worth $198.0K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 6/9/2026ACC: 0001820885-26-000008
Officer· SVP, Diagnostics, clonoSEQ
Since Aug 2020
-11K
Net shares
Net seller
$198.0K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
11K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−11K
Price / share
$18.00
Trade value
$198K
% of position
2.6%
6/4/2026
427.77K→416.77K
Total
Net shares
−11K
Net value
-$198K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 6/4/2026 | S · Sale | −11K | $18.00 | $198K | 2.6% | 427.77K | 416.77K |
| Total | −11K | -$198K | ||||||
Derivative Transactions0
No derivative transactions reported